Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Mar 21 2022

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-21-2022-5

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 21-Mar-2022 titled Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases